Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle

Summary

The objective of this study is to evaluate the efficacy and safety of Chondron (Autologus Chondrocyte) in patients with cartilage defects in their ankle for 18 months

Timeline

Start

2010-01

Primary completion

2015-05

Completion

2015-11

Outcome

Outcome not reported

Stopped: “The study was terminated early due to company reasons.”

Drugs

Indications